Development Level

Tbio 7 | 11,445

IMPC Phenotype

abnormal kidney morphology 1 | 65
prolonged QT interval 1 | 38
prolonged ST segment 1 | 36

Disease

Cancer 6 | 2,499
Gastritis 5 | 47
Diarrhea 4 | 253
Duodenal ulcer 4 | 20
Pancreatitis 4 | 123
Adenoma 3 | 167
Constipation 3 | 181
Duodenogastric reflux 3 | 8
Exocrine pancreatic insufficiency 3 | 32
Pancreatic cholera 3 | 6
Schizophrenia 3 | 1,160
Steatorrhea 3 | 34
adult high grade glioma 3 | 3,801
cystic fibrosis 3 | 1,696
diabetes mellitus 3 | 1,728
ependymoma 3 | 4,679
group 3 medulloblastoma 3 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
oligodendroglioma 3 | 2,850
Acromegaly 2 | 51
Anemia 2 | 365
Astrocytoma, Pilocytic 2 | 3,081
Autistic Disorder 2 | 364
Bile reflux 2 | 9
Bipolar Disorder 2 | 666
Breast cancer 2 | 3,578
Cholestasis 2 | 155
Down syndrome 2 | 499
Dyspepsia 2 | 33
Gastric ulcer 2 | 33
Gastroesophageal reflux disease 2 | 110
Gastrointestinal Diseases 2 | 12
Hyperparathyroidism 2 | 48
Hypoglycemia 2 | 152
Irritable bowel syndrome 2 | 60
Multiple Endocrine Neoplasia Type 1 2 | 29
Pernicious anemia 2 | 9
Stomach Neoplasms 2 | 300
Tachycardia 2 | 43
Vitamin B12 deficiency 2 | 20
Zollinger-Ellison syndrome 2 | 18
astrocytic glioma 2 | 2,597
atypical teratoid / rhabdoid tumor 2 | 5,112
glioblastoma 2 | 5,792
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
lung carcinoma 2 | 2,843
medulloblastoma, large-cell 2 | 6,241
osteosarcoma 2 | 7,950
primitive neuroectodermal tumor 2 | 3,035
psoriasis 2 | 6,694
3-methylglutaconic aciduria type 1 1 | 7
Absence of intrinsic factor 1 | 1
Achalasia 1 | 13
Adenocarcinoma 1 | 122
Anemia, Megaloblastic 1 | 16
Anorexia 1 | 43
Barrett Esophagus 1 | 16
Blind loop syndrome 1 | 2
Bone marrow biopsy shows megaloblastic erythroid hyperplasia 1 | 1
Catalepsy 1 | 15
Celiac disease 1 | 116
Cholecystitis 1 | 18
Cholera 1 | 34
Congenital deficiency of intrinsic factor 1 | 1
Depressed mood 1 | 17
Diphyllobothriasis 1 | 6
Dumping syndrome 1 | 8
Eating disorder 1 | 26
Edema 1 | 81
Esophagitis 1 | 35
Flushing 1 | 60
Gastroparesis 1 | 22
Glossitis 1 | 4
Head and Neck Neoplasms 1 | 26
Hirschsprung's disease 1 | 46
Hyperactive behavior 1 | 91
Hypercalcemia 1 | 59
Hyperglycemia 1 | 137
Hyperkinesis 1 | 32
Hypesthesia 1 | 7
Hypokalemia 1 | 52
Hypotension 1 | 82
Intrinsic Factor Deficiency 1 | 1
Liver Neoplasms, Experimental 1 | 59
Malabsorption of vitamin B12 (cyanocobalamin) 1 | 2
Manic 1 | 14
Manic mood 1 | 6
Mean cell volume increased 1 | 5
Megaloblastic Erythroid Hyperplasia 1 | 1
Neoplasm Metastasis 1 | 168
Pain 1 | 103
Panic disorder 1 | 61
Peutz-Jeghers syndrome 1 | 21
Rhinitis 1 | 54
Short bowel syndrome 1 | 16
Tropical sprue 1 | 5
Vitamin B12 deficiency caused by intestinal malabsorption 1 | 2
congenital intrinsic factor deficiency 1 | 1
non-small cell lung cancer and chronic obstructive pulmonary disease 1 | 8

Tissue

Digestive Tract 7 | 17,369
Endocrine System 7 | 18,159
Female tissues 7 | 17,400
Nervous System 7 | 16,725
Liver and Pancreas 6 | 16,750
Male tissues 6 | 17,142
Skin and soft tissues 6 | 17,230
Blood and immune system 5 | 16,909
Respiratory system 5 | 16,393
Urinary Tract 3 | 16,678
Cardiovascular System 2 | 15,192

Target Family

Non-IDG 7 | 12,091

WikiPathways Pathway

Gastric acid production 7 | 7
PI3K-Akt Signaling Pathway 338 | 338
Focal Adhesion-PI3K-Akt-mTOR-s... 303 | 303
GPCRs, Class A Rhodopsin-like 258 | 258
MAPK Signaling Pathway 245 | 245
VEGFA-VEGFR2 Signaling Pathway 235 | 235
Focal Adhesion 206 | 206
Circadian rythm related genes 200 | 200
Vitamin D Receptor Pathway 196 | 196
Ras Signaling 182 | 182
Metapathway biotransformation ... 172 | 172
Allograft Rejection 168 | 168
Chemokine signaling pathway 164 | 164
EGF/EGFR Signaling Pathway 162 | 162
Insulin Signaling 160 | 160
EMT transition in Colorectal C... 159 | 159
Myometrial Relaxation and Cont... 159 | 159
Sudden Infant Death Syndrome (... 157 | 157
Calcium Regulation in the Card... 152 | 152
Integrated Breast Cancer Pathw... 152 | 152
Regulation of Actin Cytoskelet... 149 | 149
Mesodermal Commitment Pathway 147 | 147
Brain-Derived Neurotrophic Fac... 144 | 144
NRF2 pathway 143 | 143
Endoderm Differentiation 141 | 141
Ectoderm Differentiation 138 | 138
Regulation of toll-like recept... 138 | 138
Wnt Signaling Pathway 135 | 135
Angiopoietin Like Protein 8 Re... 132 | 132
TGF-beta Signaling Pathway 132 | 132
Adipogenesis 130 | 130
Proteasome Degradation 129 | 129
mRNA Processing 125 | 125
ESC Pluripotency Pathways 116 | 116
Spinal Cord Injury 116 | 116
DNA Damage Response (only ATM ... 112 | 112
Senescence and Autophagy in Ca... 106 | 106
Cell Cycle 104 | 104
Electron Transport Chain 103 | 103
Neural Crest Differentiation 101 | 101
Toll-like Receptor Signaling P... 101 | 101
Wnt Signaling Pathway and Plur... 101 | 101
Integrin-mediated Cell Adhesio... 100 | 100
B Cell Receptor Signaling Path... 97 | 97
Corticotropin-releasing hormon... 95 | 95
G Protein Signaling Pathways 94 | 94
Amino Acid metabolism 92 | 92
Apoptosis Modulation and Signa... 92 | 92
GPCRs, Other 92 | 92
TNF alpha Signaling Pathway 92 | 92
T-Cell antigen Receptor (TCR) ... 90 | 90
Androgen receptor signaling pa... 89 | 89
Cytoplasmic Ribosomal Proteins 89 | 89
Retinoblastoma (RB) in Cancer 87 | 87
Apoptosis 86 | 86
Selenium Micronutrient Network 85 | 85
Pyrimidine metabolism 84 | 84
Signaling Pathways in Glioblas... 83 | 83
Alzheimers Disease 82 | 82
MicroRNAs in cardiomyocyte hyp... 82 | 82
DNA IR-damage and cellular res... 80 | 80
Notch Signaling Pathway 79 | 79
Leptin signaling pathway 76 | 76
Prolactin Signaling Pathway 76 | 76
Peptide GPCRs 75 | 75
Arrhythmogenic Right Ventricul... 74 | 74
Chromosomal and microsatellite... 74 | 74
miRNA Regulation of DNA Damage... 73 | 73
Primary Focal Segmental Glomer... 72 | 72
Type II interferon signaling (... 71 | 71
DNA Damage Response 69 | 69
G1 to S cell cycle control 69 | 69
Parkin-Ubiquitin Proteasomal S... 69 | 69
Sterol Regulatory Element-Bind... 69 | 69
AMP-activated Protein Kinase (... 68 | 68
Human Thyroid Stimulating Horm... 68 | 68
PPAR signaling pathway 67 | 67
Rac1/Pak1/p38/MMP-2 pathway 67 | 67
AGE/RAGE pathway 66 | 66
Association Between Physico-Ch... 66 | 66
Folate Metabolism 65 | 65
Oncostatin M Signaling Pathway 65 | 65
Lung fibrosis 64 | 64
Pathways Affected in Adenoid C... 64 | 64
Endometrial cancer 63 | 63
Endochondral Ossification 62 | 62
MECP2 and Associated Rett Synd... 62 | 62
Oxidation by Cytochrome P450 62 | 62
TYROBP Causal Network 61 | 61
Oxidative phosphorylation 60 | 60
T-Cell antigen Receptor (TCR) ... 60 | 60
Complement and Coagulation Cas... 59 | 59
Kit receptor signaling pathway 59 | 59
RIG-I-like Receptor Signaling 59 | 59
Preimplantation Embryo 58 | 58
DNA IR-Double Strand Breaks (D... 56 | 56
IL-1 signaling pathway 55 | 55
MET in type 1 papillary renal ... 55 | 55
RANKL/RANK (Receptor activator... 55 | 55
Pathogenic Escherichia coli in... 54 | 54
TGF-beta Receptor Signaling 54 | 54

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
VIP peptides VIP Tbio Non-IDG -3.55718 4092.5 322
Gastrin GAST Tbio Non-IDG -3.90567 8162.7 320
Gastrin-releasing peptide GRP Tbio Non-IDG -3.41042 2788.9 199
Cholecystokinin CCK Tbio Non-IDG -3.86274 7612.1 180
Gastric intrinsic factor GIF Tbio Non-IDG -3.20615 1559.4 172
Secretin SCT Tbio Non-IDG -3.10226 1164.7 155
Mucin-6 MUC6 Tbio Non-IDG -2.27683 174.7 140